Profiel
Ms. Amy Conrad is a Founder & Chief Executive Officer at Juniper Point, Inc. and a Head-Investor Relations at Tyra Biosciences, Inc. Ms. Conrad was previously employed as a Head-Investor Relations by Anadys Pharmaceuticals, Inc., a Head-Investor Relations by Bionano Genomics, Inc., and an Investor Relations & Media Contact by Regulus Therapeutics, Inc.
Actieve functies van Amy Conrad
Bedrijven | Functie | Begin |
---|---|---|
TYRA BIOSCIENCES, INC. | Investor Relations Contact | - |
Juniper Point, Inc. | Algemeen Directeur | - |
Eerdere bekende functies van Amy Conrad
Bedrijven | Functie | Einde |
---|---|---|
REGULUS THERAPEUTICS INC. | Investor Relations Contact | 01-01-2016 |
BIONANO GENOMICS, INC. | Investor Relations Contact | - |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
TYRA BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Juniper Point, Inc. |